COMT and schizophrenia: COMT hypomethylation has primarily been observed in patients with schizophrenia and bipolar disorder [93,94,95,96], and it is speculated that it may represent an epigenetic biomarker for both disorders [97] and part of the risk mechanism for decreased executive function [96].